These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38898119)

  • 1. Eribulin induces micronuclei and enhances the nuclear localization of cGAS in triple-negative breast cancer cells.
    Yamada H; Takada M; Ghone D; Yu M; Nagashima T; Fujimoto H; Sakakibara J; Hasegawa Y; Takao S; Yamada A; Narui K; Ishikawa T; Suzuki A; Otsuka M
    Sci Rep; 2024 Jun; 14(1):14146. PubMed ID: 38898119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eribulin induces micronuclei and enhances the nuclear localization of cGAS in triple-negative breast cancer cells.
    Yamada H; Takada M; Ghone D; Yu M; Nagashima T; Fujimoto H; Sakakibara J; Hasegawa Y; Takao S; Yamada A; Narui K; Ishikawa T; Suzuki A; Otsuka M
    Res Sq; 2023 Dec; ():. PubMed ID: 38106033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA.
    Fermaintt CS; Takahashi-Ruiz L; Liang H; Mooberry SL; Risinger AL
    Mol Pharmacol; 2021 Oct; 100(4):309-318. PubMed ID: 34312217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers.
    Hong C; Schubert M; Tijhuis AE; Requesens M; Roorda M; van den Brink A; Ruiz LA; Bakker PL; van der Sluis T; Pieters W; Chen M; Wardenaar R; van der Vegt B; Spierings DCJ; de Bruyn M; van Vugt MATM; Foijer F
    Nature; 2022 Jul; 607(7918):366-373. PubMed ID: 35705809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients.
    Vasiyani H; Mane M; Rana K; Shinde A; Roy M; Singh J; Gohel D; Currim F; Srivastava R; Singh R
    Apoptosis; 2022 Dec; 27(11-12):961-978. PubMed ID: 36018392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels.
    Basit A; Cho MG; Kim EY; Kwon D; Kang SJ; Lee JH
    Exp Mol Med; 2020 Apr; 52(4):643-657. PubMed ID: 32284536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer.
    Hu Y; Manasrah BK; McGregor SM; Lera RF; Norman RX; Tucker JB; Scribano CM; Yan RE; Humayun M; Wisinski KB; Tevaarwerk AJ; O'Regan RM; Wilke LG; Weaver BA; Beebe DJ; Jin N; Burkard ME
    Mol Cancer Ther; 2021 Dec; 20(12):2553-2567. PubMed ID: 34583980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage-triggered activation of cGAS-STING pathway induces apoptosis in human keratinocyte HaCaT cells.
    Li C; Liu W; Wang F; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Mol Immunol; 2021 Mar; 131():180-190. PubMed ID: 33423764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth of triple-negative breast cancer cells with the suppression of survivin, Bcl-xL, and the MAPK pathway.
    Ono H; Sowa Y; Horinaka M; Iizumi Y; Watanabe M; Morita M; Nishimoto E; Taguchi T; Sakai T
    Breast Cancer Res Treat; 2018 Aug; 171(1):43-52. PubMed ID: 29752686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer.
    Bagheri M; Lee MK; Muller KE; Miller TW; Pattabiraman DR; Christensen BC
    Epigenomics; 2024 Mar; 16(5):293-308. PubMed ID: 38356412
    [No Abstract]   [Full Text] [Related]  

  • 11. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells.
    Vasiyani H; Shinde A; Roy M; Mane M; Singh K; Singh J; Gohel D; Currim F; Vaidya K; Chhabria M; Singh R
    Apoptosis; 2021 Jun; 26(5-6):293-306. PubMed ID: 33840002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micronuclei induced by radiation, replication stress, or chromosome segregation errors do not activate cGAS-STING.
    Takaki T; Millar R; Hiley CT; Boulton SJ
    Mol Cell; 2024 Jun; 84(11):2203-2213.e5. PubMed ID: 38749421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA drives noncanonical inflammation activation via cGAS-STING signaling pathway in retinal microvascular endothelial cells.
    Guo Y; Gu R; Gan D; Hu F; Li G; Xu G
    Cell Commun Signal; 2020 Oct; 18(1):172. PubMed ID: 33115500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micronucleus is not a potent inducer of the cGAS/STING pathway.
    Sato Y; Hayashi MT
    Life Sci Alliance; 2024 Apr; 7(4):. PubMed ID: 38307626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer.
    Zhao Q; Hughes R; Neupane B; Mickle K; Su Y; Chabot I; Betts M; Kadambi A
    BMC Cancer; 2021 Jun; 21(1):758. PubMed ID: 34193107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cGAS-STING Pathway: Novel Perspectives in Liver Diseases.
    Xu D; Tian Y; Xia Q; Ke B
    Front Immunol; 2021; 12():682736. PubMed ID: 33995425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.
    Chabanon RM; Muirhead G; Krastev DB; Adam J; Morel D; Garrido M; Lamb A; Hénon C; Dorvault N; Rouanne M; Marlow R; Bajrami I; Cardeñosa ML; Konde A; Besse B; Ashworth A; Pettitt SJ; Haider S; Marabelle A; Tutt AN; Soria JC; Lord CJ; Postel-Vinay S
    J Clin Invest; 2019 Mar; 129(3):1211-1228. PubMed ID: 30589644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear cGAS suppresses DNA repair and promotes tumorigenesis.
    Liu H; Zhang H; Wu X; Ma D; Wu J; Wang L; Jiang Y; Fei Y; Zhu C; Tan R; Jungblut P; Pei G; Dorhoi A; Yan Q; Zhang F; Zheng R; Liu S; Liang H; Liu Z; Yang H; Chen J; Wang P; Tang T; Peng W; Hu Z; Xu Z; Huang X; Wang J; Li H; Zhou Y; Liu F; Yan D; Kaufmann SHE; Chen C; Mao Z; Ge B
    Nature; 2018 Nov; 563(7729):131-136. PubMed ID: 30356214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer.
    Xiang J; Hurchla MA; Fontana F; Su X; Amend SR; Esser AK; Douglas GJ; Mudalagiriyappa C; Luker KE; Pluard T; Ademuyiwa FO; Romagnoli B; Tuffin G; Chevalier E; Luker GD; Bauer M; Zimmermann J; Aft RL; Dembowsky K; Weilbaecher KN
    Mol Cancer Ther; 2015 Nov; 14(11):2473-85. PubMed ID: 26269605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
    Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.